Omega 3 Fatty Acid: US vs India

Market size, growth to 2033 and clinical trials, side by side.

The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $75 Mn in 2023, about 23 times as large.

India grows faster: 10.4% a year, against 5.4%. The gap still grows from $1.6 Bn to $2.7 Bn by 2033.

Clinical research: 133 active trials in the US, 7 in India.

Omega 3 Fatty Acid: US compared with India
Measure US India
Market size, 2023$1.7 Bn$75 Mn
Market size, 2033 projected$2.9 Bn$201 Mn
Growth a year (CAGR)5.4%10.4%
Money added, 2023–2033$1.2 Bn$126 Mn
Share of the world market42%1.8%
Size rank of 24 countries#1#12
Market per person, 2023$5.04$0.05
Active clinical trials 133 7
Full reportUS report India report

Year by year, 2023 to 2033

US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.

Quick answers

Which is bigger in Omega 3 Fatty Acid, US or India?

The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $75 Mn in 2023, about 23 times as large.

Which grows faster in Omega 3 Fatty Acid, US or India?

India grows faster: 10.4% a year, against 5.4%. The gap still grows from $1.6 Bn to $2.7 Bn by 2033.

More Omega 3 Fatty Acid comparisons

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.